Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.
Identifieur interne : 005043 ( Main/Exploration ); précédent : 005042; suivant : 005044Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.
Auteurs : Heike Hofmann [Allemagne] ; Martina Geier ; Andrea Marzi ; Mandy Krumbiegel ; Matthias Peipp ; Georg H. Fey ; Thomas Gramberg ; Stefan PöhlmannSource :
- Biochemical and biophysical research communications [ 0006-291X ] ; 2004.
Descripteurs français
- KwdFr :
- Alignement de séquences, Animaux, Antiviraux (), Antiviraux (métabolisme), Carboxypeptidases (), Carboxypeptidases (génétique), Carboxypeptidases (métabolisme), Humains, Lignée cellulaire, Mutation, Peptidyl-Dipeptidase A, Protéines virales (métabolisme), Récepteurs viraux (métabolisme), Solubilité, Structure tertiaire des protéines, Susceptibilité à une maladie, Syndrome respiratoire aigu sévère (métabolisme), Séquence d'acides aminés, Virus du SRAS (métabolisme), Virus du SRAS (pathogénicité).
- MESH :
- génétique : Carboxypeptidases.
- métabolisme : Antiviraux, Carboxypeptidases, Protéines virales, Récepteurs viraux, Syndrome respiratoire aigu sévère, Virus du SRAS.
- pathogénicité : Virus du SRAS.
- Alignement de séquences, Animaux, Antiviraux, Carboxypeptidases, Humains, Lignée cellulaire, Mutation, Peptidyl-Dipeptidase A, Solubilité, Structure tertiaire des protéines, Susceptibilité à une maladie, Séquence d'acides aminés.
English descriptors
- KwdEn :
- Amino Acid Sequence, Animals, Antiviral Agents (chemistry), Antiviral Agents (metabolism), Carboxypeptidases (chemistry), Carboxypeptidases (genetics), Carboxypeptidases (metabolism), Cell Line, Disease Susceptibility, Humans, Mutation, Peptidyl-Dipeptidase A, Protein Structure, Tertiary, Receptors, Virus (metabolism), SARS Virus (metabolism), SARS Virus (pathogenicity), Sequence Alignment, Severe Acute Respiratory Syndrome (metabolism), Solubility, Viral Proteins (metabolism).
- MESH :
- chemical , chemistry : Antiviral Agents, Carboxypeptidases.
- chemical , genetics : Carboxypeptidases.
- chemical , metabolism : Antiviral Agents, Carboxypeptidases, Receptors, Virus, Viral Proteins.
- metabolism : SARS Virus, Severe Acute Respiratory Syndrome.
- pathogenicity : SARS Virus.
- Amino Acid Sequence, Animals, Cell Line, Disease Susceptibility, Humans, Mutation, Peptidyl-Dipeptidase A, Protein Structure, Tertiary, Sequence Alignment, Solubility.
Abstract
The angiotensin converting enzyme 2 (ACE2) has been identified as a receptor for the severe acute respiratory syndrome associated coronavirus (SARS-CoV). Here we show that ACE2 expression on cell lines correlates with susceptibility to SARS-CoV S-driven infection, suggesting that ACE2 is a major receptor for SARS-CoV. The soluble ectodomain of ACE2 specifically abrogated S-mediated infection and might therefore be exploited for the generation of inhibitors. Deletion of a major portion of the cytoplasmic domain of ACE2 had no effect on S-driven infection, indicating that this domain is not important for receptor function. Our results point to a central role of ACE2 in SARS-CoV infection and suggest a minor contribution of the cytoplasmic domain to receptor function.
DOI: 10.1016/j.bbrc.2004.05.114
PubMed: 15194496
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002D40
- to stream PubMed, to step Curation: 002D40
- to stream PubMed, to step Checkpoint: 002A04
- to stream Ncbi, to step Merge: 000867
- to stream Ncbi, to step Curation: 000867
- to stream Ncbi, to step Checkpoint: 000867
- to stream Main, to step Merge: 005409
- to stream Main, to step Curation: 005043
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.</title>
<author><name sortKey="Hofmann, Heike" sort="Hofmann, Heike" uniqKey="Hofmann H" first="Heike" last="Hofmann">Heike Hofmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Chair of Genetics, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Chair of Genetics, University of Erlangen-Nürnberg, 91054 Erlangen</wicri:regionArea>
<wicri:noRegion>91054 Erlangen</wicri:noRegion>
<placeName><settlement type="city">Erlangen</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Moyenne-Franconie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Geier, Martina" sort="Geier, Martina" uniqKey="Geier M" first="Martina" last="Geier">Martina Geier</name>
</author>
<author><name sortKey="Marzi, Andrea" sort="Marzi, Andrea" uniqKey="Marzi A" first="Andrea" last="Marzi">Andrea Marzi</name>
</author>
<author><name sortKey="Krumbiegel, Mandy" sort="Krumbiegel, Mandy" uniqKey="Krumbiegel M" first="Mandy" last="Krumbiegel">Mandy Krumbiegel</name>
</author>
<author><name sortKey="Peipp, Matthias" sort="Peipp, Matthias" uniqKey="Peipp M" first="Matthias" last="Peipp">Matthias Peipp</name>
</author>
<author><name sortKey="Fey, Georg H" sort="Fey, Georg H" uniqKey="Fey G" first="Georg H" last="Fey">Georg H. Fey</name>
</author>
<author><name sortKey="Gramberg, Thomas" sort="Gramberg, Thomas" uniqKey="Gramberg T" first="Thomas" last="Gramberg">Thomas Gramberg</name>
</author>
<author><name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15194496</idno>
<idno type="pmid">15194496</idno>
<idno type="doi">10.1016/j.bbrc.2004.05.114</idno>
<idno type="wicri:Area/PubMed/Corpus">002D40</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002D40</idno>
<idno type="wicri:Area/PubMed/Curation">002D40</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002D40</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A04</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A04</idno>
<idno type="wicri:Area/Ncbi/Merge">000867</idno>
<idno type="wicri:Area/Ncbi/Curation">000867</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000867</idno>
<idno type="wicri:doubleKey">0006-291X:2004:Hofmann H:susceptibility:to:sars</idno>
<idno type="wicri:Area/Main/Merge">005409</idno>
<idno type="wicri:Area/Main/Curation">005043</idno>
<idno type="wicri:Area/Main/Exploration">005043</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.</title>
<author><name sortKey="Hofmann, Heike" sort="Hofmann, Heike" uniqKey="Hofmann H" first="Heike" last="Hofmann">Heike Hofmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Chair of Genetics, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Chair of Genetics, University of Erlangen-Nürnberg, 91054 Erlangen</wicri:regionArea>
<wicri:noRegion>91054 Erlangen</wicri:noRegion>
<placeName><settlement type="city">Erlangen</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Moyenne-Franconie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Geier, Martina" sort="Geier, Martina" uniqKey="Geier M" first="Martina" last="Geier">Martina Geier</name>
</author>
<author><name sortKey="Marzi, Andrea" sort="Marzi, Andrea" uniqKey="Marzi A" first="Andrea" last="Marzi">Andrea Marzi</name>
</author>
<author><name sortKey="Krumbiegel, Mandy" sort="Krumbiegel, Mandy" uniqKey="Krumbiegel M" first="Mandy" last="Krumbiegel">Mandy Krumbiegel</name>
</author>
<author><name sortKey="Peipp, Matthias" sort="Peipp, Matthias" uniqKey="Peipp M" first="Matthias" last="Peipp">Matthias Peipp</name>
</author>
<author><name sortKey="Fey, Georg H" sort="Fey, Georg H" uniqKey="Fey G" first="Georg H" last="Fey">Georg H. Fey</name>
</author>
<author><name sortKey="Gramberg, Thomas" sort="Gramberg, Thomas" uniqKey="Gramberg T" first="Thomas" last="Gramberg">Thomas Gramberg</name>
</author>
<author><name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name>
</author>
</analytic>
<series><title level="j">Biochemical and biophysical research communications</title>
<idno type="ISSN">0006-291X</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (metabolism)</term>
<term>Carboxypeptidases (chemistry)</term>
<term>Carboxypeptidases (genetics)</term>
<term>Carboxypeptidases (metabolism)</term>
<term>Cell Line</term>
<term>Disease Susceptibility</term>
<term>Humans</term>
<term>Mutation</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protein Structure, Tertiary</term>
<term>Receptors, Virus (metabolism)</term>
<term>SARS Virus (metabolism)</term>
<term>SARS Virus (pathogenicity)</term>
<term>Sequence Alignment</term>
<term>Severe Acute Respiratory Syndrome (metabolism)</term>
<term>Solubility</term>
<term>Viral Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Alignement de séquences</term>
<term>Animaux</term>
<term>Antiviraux ()</term>
<term>Antiviraux (métabolisme)</term>
<term>Carboxypeptidases ()</term>
<term>Carboxypeptidases (génétique)</term>
<term>Carboxypeptidases (métabolisme)</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Mutation</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protéines virales (métabolisme)</term>
<term>Récepteurs viraux (métabolisme)</term>
<term>Solubilité</term>
<term>Structure tertiaire des protéines</term>
<term>Susceptibilité à une maladie</term>
<term>Syndrome respiratoire aigu sévère (métabolisme)</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS (métabolisme)</term>
<term>Virus du SRAS (pathogénicité)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
<term>Carboxypeptidases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Carboxypeptidases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antiviral Agents</term>
<term>Carboxypeptidases</term>
<term>Receptors, Virus</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Carboxypeptidases</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Antiviraux</term>
<term>Carboxypeptidases</term>
<term>Protéines virales</term>
<term>Récepteurs viraux</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Disease Susceptibility</term>
<term>Humans</term>
<term>Mutation</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Protein Structure, Tertiary</term>
<term>Sequence Alignment</term>
<term>Solubility</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Alignement de séquences</term>
<term>Animaux</term>
<term>Antiviraux</term>
<term>Carboxypeptidases</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Mutation</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Solubilité</term>
<term>Structure tertiaire des protéines</term>
<term>Susceptibilité à une maladie</term>
<term>Séquence d'acides aminés</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The angiotensin converting enzyme 2 (ACE2) has been identified as a receptor for the severe acute respiratory syndrome associated coronavirus (SARS-CoV). Here we show that ACE2 expression on cell lines correlates with susceptibility to SARS-CoV S-driven infection, suggesting that ACE2 is a major receptor for SARS-CoV. The soluble ectodomain of ACE2 specifically abrogated S-mediated infection and might therefore be exploited for the generation of inhibitors. Deletion of a major portion of the cytoplasmic domain of ACE2 had no effect on S-driven infection, indicating that this domain is not important for receptor function. Our results point to a central role of ACE2 in SARS-CoV infection and suggest a minor contribution of the cytoplasmic domain to receptor function.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bavière</li>
<li>District de Moyenne-Franconie</li>
</region>
<settlement><li>Erlangen</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Fey, Georg H" sort="Fey, Georg H" uniqKey="Fey G" first="Georg H" last="Fey">Georg H. Fey</name>
<name sortKey="Geier, Martina" sort="Geier, Martina" uniqKey="Geier M" first="Martina" last="Geier">Martina Geier</name>
<name sortKey="Gramberg, Thomas" sort="Gramberg, Thomas" uniqKey="Gramberg T" first="Thomas" last="Gramberg">Thomas Gramberg</name>
<name sortKey="Krumbiegel, Mandy" sort="Krumbiegel, Mandy" uniqKey="Krumbiegel M" first="Mandy" last="Krumbiegel">Mandy Krumbiegel</name>
<name sortKey="Marzi, Andrea" sort="Marzi, Andrea" uniqKey="Marzi A" first="Andrea" last="Marzi">Andrea Marzi</name>
<name sortKey="Peipp, Matthias" sort="Peipp, Matthias" uniqKey="Peipp M" first="Matthias" last="Peipp">Matthias Peipp</name>
<name sortKey="Pohlmann, Stefan" sort="Pohlmann, Stefan" uniqKey="Pohlmann S" first="Stefan" last="Pöhlmann">Stefan Pöhlmann</name>
</noCountry>
<country name="Allemagne"><region name="Bavière"><name sortKey="Hofmann, Heike" sort="Hofmann, Heike" uniqKey="Hofmann H" first="Heike" last="Hofmann">Heike Hofmann</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005043 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005043 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:15194496 |texte= Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15194496" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |